Effect Analysis of Recombinant Bovine Basic Fibroblast Growth Factor Eye Gel+Tobramycin Dexamethasone Eye Drops in the Treatment of Dry Eye after Cataract Operation
Objective To analyze the effect of combined application of recombinant bovine basic fibroblast growth fac-tor eye gel and tobramycin dexamethasone eye drops in dry eye after cataract surgery.Methods A total of 288 patients with dry eye after cataract surgery admitted to Foshan Huaxia Eye Hospital from January 2019 to March 2024 were non-randomly selected as the research objects.According to different treatment methods,they were divided into con-trol group and study group,with 144 cases in each group.The control group was treated with recombinant bovine basic fibroblast growth factor eye gel alone,and the study group was treated with tobramycin and dexamethasone eye drops on the basis of the control group.The clinical efficacy,ocular symptoms before and after treatment,tear film stability before and after treatment and the incidence of adverse reactions were compared between the two groups.Results The total effective rate of the study group was 98.61%(142/144),which was higher than 88.89%(128/144)of the control group,the difference was statistically significant(χ2=11.989,P<0.05).There was no significant difference in ocular symptoms and tear film stability between the two groups before treatment(all P>0.05).After treatment,ocular symp-tom scores and tear film stability indexes in both groups were better than those before treatment,and the study group was better than the control group,the differences were statistically significant(all P<0.05).There was no significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion The combination of tobramycin dexamethasone eye drops and recombinant bovine basic fibroblast growth factor eye gel in the treatment of dry eye after cataract surgery is effective,can effectively improve the ocular symptoms of patients,improve the sta-bility of tear film,and do not increase the adverse drug reaction.
NETL
NSTL
万方数据
